RxDoctor Payments DataLook up a doctor →

Grace Odi, MD

Hospitalist · Houston, TXNPI 1922398528

Payments from drug & device makers

$14,393in general payments, 2019–2025

Across 753 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Amgen$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Pfizer$541
  • AbbVie$527
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,378100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk120$1,892
Amgen(2 entities)80$1,682
Lilly USA, LLC66$1,341
AstraZeneca(2 entities)44$1,260
Pfizer30$541
AbbVie32$527
Corcept Therapeutics24$447
Sanofi-aventis U.S. LLC25$442
Esperion Therapeutics, Inc.13$430
Mannkind Corporation31$398
Boehringer Ingelheim17$385
Abbott15$381
Radius Health, Inc.18$294
Amneal Pharmaceuticals LLC17$275
Exact Sciences13$243
Kowa Pharmaceuticals America, Inc.13$216
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$197
Insulet Corporation10$188
IBSA Pharma Inc.11$177
Valeritas, Inc.17$176
Takeda Pharmaceuticals U.S.A., Inc.9$170
Inspire Medical Systems, Inc.7$166
Vivus LLC10$165
GRT US Holding, Inc.3$153
Cequr Corporation3$148
GSK7$143
Amarin Pharma, Inc.9$137
Tandem Diabetes Care, Inc.6$133
Ascendis Pharma Endocrinology Inc5$126
Bayer7$123
Sanofi Pasteur Inc.4$94
Tolmar, Inc.5$93
Boston Scientific4$91
Dexcom, Inc.5$91
BETA Bionics, Inc.5$81
Arbor Pharmaceuticals, Inc.5$76
Johnson & Johnson5$71
Xeris Pharmaceuticals, Inc.4$70
Astellas Pharma US Inc3$63
Biohaven Pharmaceuticals, Inc.3$55
Phadia US Inc.3$53
Merck4$47
Verity Pharmaceuticals Inc.2$43
Kyowa Kirin, Inc.2$41
Shire North American Group Inc2$41
Medtronic2$39
Neurocrine Biosciences, Inc.1$38
Vertical Pharmaceuticals, LLC2$37
Madrigal Pharmaceuticals1$36
Ultragenyx Pharmaceutical Inc.2$36
Embecta Corp.1$28
Antares Pharma, Inc.2$26
Dynavax Technologies Corporation1$25
Recordati_rare_diseases_inc.1$22
Halozyme Inc1$22
Zealand Pharma US, Inc.1$20
Idorsia Pharmaceuticals US Inc1$18
Ironwood Pharmaceuticals, Inc1$18
Ipsen Biopharmaceuticals, Inc1$18
Therapeuticsmd, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,393 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.

See all hospitalist providers in Texas

Medicare billing

Part B allowed, 2024
$36,463
Medicare patients
98
Services billed
300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide109$157,087
OzempicSemaglutide89$129,400
TrulicityDulaglutide49$64,270
JanuviaSitagliptin Phosphate51$56,860
JardianceEmpagliflozin30$49,319
EliquisApixaban33$37,388
FarxigaDapagliflozin Propanediol16$19,215
LinzessLinaclotide13$16,104
LyricaPregabalin13$13,645
Praluent PenAlirocumab20$9,559
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$6,098
SymbicortBudesonide/Formoterol Fumarate14$3,824
Rosuvastatin Calcium176$2,618
SynthroidLevothyroxine Sodium31$2,461
Nifedipine ErNifedipine53$2,445

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,341$221,358158 claims
Novo NordiskOzempic$1,892$129,40089 claims
MerckJanuvia$47$56,86051 claims
PfizerEliquis, Lyrica$541$51,03246 claims
Boehringer IngelheimJardiance$385$49,31930 claims
AstraZenecaFarxiga, Symbicort$1,260$23,03930 claims
AbbVieLinzess, Synthroid$527$18,56644 claims
IBSA Pharma Inc.Tirosint-Sol$177$1,71612 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$275$1,679110 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 hospitalist providers in Texas.

Other hospitalist in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →